FDA to Re-Examine Rational Opioid Prescribing, Starting with Acute Pain – By Angie Drakulich – Aug 2018
The US Food and Drug Administration continues to seek ways to curb the opioid epidemic—with the agency’s latest efforts turned toward preventing diversion, misuse, or abuse at the acute level.
This is the agency that should be managing opioid guideline development, not the CDC and certainly not the DEA.
Could this be the start of a more sane and compassionate guideline for treating intractable pain with opioids after all else has failed? Continue reading
New FDA Initiative Implies CDC Opioid Guidelines Are Not Evidence-Based – August 23, 2018 – By Jeffrey A. Singer
On August 22, Food and Drug Commissioner Scott Gottlieb issued a press release announcing the FDA plans to contract with the National Academies of Sciences, Engineering, and Medicine (NASEM) to develop evidence-based guidelines for the appropriate prescribing of opioids for acute and post-surgical pain.
The press release stated:
The primary scope of this work is to understand what evidence is needed to ensure that all current and future clinical practice guidelines for opioid analgesic prescribing are sufficient, and what research is needed to generate that evidence in a practical and feasible manner. Continue reading
CDC opioid guideline is causing harm to people in chronic pain – By Dr. Lynn Webster – Aug 2018
On March 15, 2016, the Centers for Disease Control and Prevention (CDC) published its Guideline for Prescribing Opioids for Chronic Pain.
Pain advocacy groups were concerned that the CDC Guideline for Prescribing Opioids for Chronic Pain could have unintended negative consequences when they were introduced.
I don’t believe these consequences were the least bit unintentional: CDC Opioid Prescribing Guideline: Unintentional Consequences? Continue reading
CDC’s new opioid guidelines will be used by plaintiffs bar, WLF says | Legal Newsline – By Jessica Karmasek | Mar 30, 2016
While this isn’t “news”, it has not been entirely resolved. Still unclear are the legality, interpretation, enforcement, and much else associated with this abomination of a guideline, written by anti-opioid zealots and wrongly codified into legislation to control medical practice.
A Washington, D.C.-based public-interest law firm that has been outspoken about the Centers for Disease Control and Prevention’s handling of an opioid guideline development team argues the agency’s new guidelines, which were issued this month, will “no doubt” have an effect on future litigation.
Richard Samp, chief counsel for the Washington Legal Foundation, argues plaintiffs law firms, including Cohen Milstein Sellers & Toll PLLC, will use the CDC’s approval and release of the guidelines to their advantage. Continue reading
The Government’s Solution To The Opioid Crisis Feels Like A War To Pain Patients – by Art Levine – July 2018
Jay Lawrence, an energetic truck driver in his late 30s, was driving a semitrailer across a bridge when the brakes failed. To avoid plowing into the car in front of him, he swerved sideways and slammed the truck into a wall, fracturing his back.
For more than 25 years, he struggled with the resulting pain. But for most of that time, he managed to avoid opioid painkillers.
In 2006, his legs suddenly collapsed beneath him, due to a complex web of neurological factors related to his spinal cord injury. He underwent multiple surgeries and tried many medications to alleviate his pain. Continue reading
Opioid policy fallout | Medical Economics – Jeff Bendix – May 30, 2018
The epidemic of opioid-related deaths sweeping the country has lawmakers and regulators in Washington, D.C., and state capitals scrambling for answers. And while doctors generally welcome the attention to the crisis, many also fear that the solutions being proposed and enacted will do more harm than good.
The concern among physicians and public health and pain management experts is that laws and regulations designed to limit use of prescription narcotics, however well-intentioned, are yet another constraint on doctors’ ability to treat patients as they think best. Continue reading
Head CDC CDC Head Wants Opioid Guidelines for Acute Pain – June 2018 By Pat Anson, Editor
The CDC has been roundly criticized in the past for how it tracked and counted opioid overdoses – erroneously mixing illicit fentanyl deaths with those linked to prescription opioids – so any improvement in that area is welcome.
But for the agency to even consider prescribing guidelines for acute pain is puzzling – considering how disastrous its guidelines have been for chronic pain.
But disastrous only if looking beyond just addiction, disastrous in terms of pain management, destroyed quality of life, ruined careers, suicides… But no government agencies are looking at anything but addiction, and then only potential addiction to prescribed medications. Continue reading
Editorial: Hubachek on the Fallout from the CDC Opioid Prescribing Guidelines – Feb 2018 – Nina Luckman
Here’s the legal viewpoint from Worker’s Compensation lawyers:
The following editorial by local claimant attorney Gregory J. Hubachek and D. Kirkhoff Brainard addresses the Center for Disease Control’s (CDC) opioid prescribing guidelines and how they believe the guidelines’ scientific support is limited.
The CDC opioid prescribing guidelines provoked an immediate and sustained outcry from physicians and pain management specialists as soon as the draft version of the document was released to the public. Continue reading
Patient Advocacy Group Offers Opioid Prescribing Recommendations – June 13, 2018 – By Richard A. Lawhern, PhD and Steven E. Nadeau, MD
I’m proud that the advocacy group I’m involved with (ATIP) has its recommendations published in this mainstream medical magazine:
Advocacy group describes why CDC Guidelines on Opioid Prescribing should be withdrawn and rewritten.
In a whitepaper titled “Principles for Patient-Centered Opioid Prescription Guidelines,”* the Alliance for the Treatment of Intractable Pain [ATIP] argues that the CDC Guidelines for Prescribing Opioids for Chronic Pain “must be withdrawn and rewritten” to recognize both the indispensable role that opioids play in chronic pain management, and the central role of physicians in assessing and prescribing medications as patients require. Continue reading